Clinical Trials Browser

Enrolling by invitation × Interventional × Daunorubicin × Clear all

NCT06697327 2025-05-14

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

Phase NA Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute